Publication | Open Access

Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro

Medicinal ChemistryQuinazoline SkeletonAnticancer ActivitiesMedicineNovel 4-Anlinoquinazoline DerivativesPharmacological AgentPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyDrug Discovery